ctrl K

Watchlist Price Alert

Coya Therapeutics Inc. (COYA)

NASDAQ: COYA · Real-Time Price · USD

5.54

0.09 (1.65%)

At close: Jun 17, 2025, 10:46 AM

Coya Therapeutics Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	3.55M	6M	n/a	n/a	n/a
Cost of Revenue	27.36K	27.36K	27.36K	16.13K	n/a
Gross Profit	3.55M	6M	-27.36K	-16.13K	n/a
Operating Income	-17.25M	-7.9M	-9.81M	-4.87M	-695K
Interest Income	n/a	n/a	n/a	n/a	n/a
Pretax Income	-15.6M	-7.26M	-12.24M	-4.89M	-733K
Net Income	-14.88M	-7.99M	-12.24M	-4.89M	-733K
Selling & General & Admin	8.89M	7.83M	4.85M	2.31M	445.8K
Research & Development	11.89M	6.04M	4.41M	2.54M	248.97K
Other Expenses	27.36K	27.36K	63.67K	16.13K	n/a
Operating Expenses	20.8M	13.91M	9.29M	4.87M	694.77K
Interest Expense	n/a	n/a	2.43M	n/a	38.98K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	445.13K
Cost & Expenses	20.8M	13.91M	9.81M	4.87M	1.04M
Income Tax Expense	-720K	723.85K	2.43M	-21.48K	-704
Shares Outstanding (Basic)	15.24M	10.16M	2.59M	9.68M	9.68M
Shares Outstanding (Diluted)	15.24M	10.16M	2.59M	6.6M	9.68M
EPS (Basic)	-0.98	-0.79	-4.73	-0.5	-0.08
EPS (Diluted)	-0.98	-0.79	-4.73	-0.5	-0.08
EBITDA	-17.22M	-7.88M	-12.22M	-4.85M	10.44K
EBIT	-17.23M	-7.9M	-12.24M	-4.87M	-694K
Depreciation & Amortization	27.36K	27.36K	27.36K	16.13K	704.65K